Bacteria: atypical and cell-wall-deficient

Chlamydia trachomatis

General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.

Overview

An obligate intracellular bacterium and the most commonly reported sexually transmitted bacterial infection in the United States.

Infections

Urethritis, cervicitis, pelvic inflammatory disease, epididymitis, proctitis, conjunctivitis; lymphogranuloma venereum (specific serovars).

Signs and symptoms

Discharge, dysuria, pelvic pain, red irritated eye; most infections cause no symptoms.

Antibiotic and antimicrobial resistance

Clinically relevant resistance is not a routine concern.

Treatment considerations

Doxycycline is preferred per CDC guidelines; azithromycin is an alternative.

Infection control and public health

Nationally notifiable; annual screening for sexually active women under 25 and others at risk; partner treatment.

Brown-stained Chlamydia trachomatis inclusion bodies inside cultured cells
Chlamydia trachomatis inclusion bodies (brown) in McCoy cell culture. Public domain. Image source
Obligate intracellular bacteria (inclusions inside a host cell), schematic
Obligate intracellular bacteria (inclusions inside a host cell). Schematic, not to scale; InnovexLab.

Sources

  1. CDC. Chlamydial infections (STI Treatment Guidelines).
  2. CDC. Sexually Transmitted Infections Treatment Guidelines, 2021.

Sources accessed November 2026. Links open external sites that InnovexLab does not control.

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.